Zack McNealy is our Chief Financial Officer with over 15 years of experience in financial leadership for biotech companies. Previously, Zack was Chief Financial Officer at Ventus Therapeutics, Chinook Therapeutics, and Inception Sciences Canada. Before joining Inception, Zack held financial leadership roles at Versant Ventures and Biotie Therapies. Prior to this, Zack worked at Johnson & Johnson. Zack has significant experience in supporting small biotech companies, including mergers & acquisitions and international structures.​

He received a BS in finance and accounting from Miami University (Ohio) and an MBA from the Wharton School of the University of Pennsylvania.